GC
ETRM

Guggenheim Capital’s EnteroMedics Inc. ETRM Stock Holding History

Guggenheim Capital’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-562
Closed -$5K – 3108
2016
Q3 		$5K Buy
+562
New +$7.63K ﹤0.01% 2880
2015
Q4 		– Sell
-11
Closed -$3K – 3212
2015
Q3 		$3K Buy
11
+1
+10% +$319 ﹤0.01% 2951
2015
Q2 		$7K Hold
10
– – ﹤0.01% 3032
2015
Q1 		$10K Hold
10
– – ﹤0.01% 3022
2014
Q4 		$15K Buy
+10
New +$13.5K ﹤0.01% 2980
2014
Q3 		– Sell
-17
Closed -$29K – 3322
2014
Q2 		$29K Sell
17
-2
-11% -$3.74K ﹤0.01% 3137
2014
Q1 		$37K Buy
19
+6
+46% +$14.2K ﹤0.01% 3172
2013
Q4 		$28K Buy
13
+1
+8% +$1.61K ﹤0.01% 3107
2013
Q3 		$16K Hold
12
– – ﹤0.01% 3031
2013
Q2 		$15K Buy
+12
New +$12.7K ﹤0.01% 3002

Other funds holding ETRM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Guggenheim Capital's ETRM Position: Q4 2016 in Review

Guggenheim Capital sold out of EnteroMedics Inc. (ETRM) in Q4 2016, closing a stake of 562 shares — an estimated $5K sold.

Guggenheim Capital first reported a position in ETRM in Q2 2013 and held it in 10 quarters. The position peaked at $37K in Q1 2014. 18 funds tracked by Wall St. Rank hold ETRM as of Q4 2016.

  • Guggenheim Capital reported no remaining EnteroMedics Inc. position as of Q4 2016 after selling out during the quarter.
  • Guggenheim Capital sold 562 EnteroMedics Inc. shares in Q4 2016, an estimated $5K.
  • Guggenheim Capital first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 10 quarters.
  • Guggenheim Capital's EnteroMedics Inc. position peaked at $37K in Q1 2014.
  • 18 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2016.

Based on Guggenheim Capital's 13F filing for Q4 2016, filed 14 Feb 2017.